BRCA1 and ovarian cancer: The Thai Gynecologic Cancer Society is aware of the increasing role of PARPi in treatment of ovarian cancer, so this study was conducted among tertiary centers for cancer care in Thailand to determine the BRCA1/2 mutation status in Thai patients with EOC.